Generic Drugs In State Health Plans

14 May 1995

In 1994, the number of US state health plans which incorporated incentives for use of generic drugs in their prescription drug coverage had gone up to 38 from 32 plans the year before, says a new study by the Seagal Company.

The study found plans introducing these incentives in Arkansas, Connecticut, Indiana, Louisiana, Oregon, Tennessee and Vermont. The only state to abandon generic incentives was in Montana.

20 state employee plans operated mail-order prescription drug benefits in 1994, one more (Oregon) than in 1993, while 25 state plans used discount pharmacy networks, against 19 the year before. 26 operated prescription drug card programs in 1994, with Minnesota, Mississippi and an Oregon plan introducing them, and Alaska dropping its drug card program.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight